Cian Healthcare Limited

Equities

CHCL

INE05BN01019

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:54 2024-05-31 am EDT 5-day change 1st Jan Change
23.42 INR -.--% Intraday chart for Cian Healthcare Limited +1.61% +37.20%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cian Healthcare to Supply 13 Pharmaceutical Products for HLL Lifecare MT
Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Cian Healthcare to Export Products to Guatemala Via New Deal MT
Cian Healthcare Limited Enters into Merchant Export Agreement with Tamil Pharma Pvt Ltd CI
Cian Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Cian Healthcare Signs Deal to Manufacture Products for Nigerian Pharmaceutical Firm MT
Cian Healthcare Limited Enters into an Agreement with CHI Pharmaceuticals Limited CI
Crisil Lowers Rating on Cian Healthcare's Bank Loans to D; Outlook MT
Crisil Gives B+ Rating to Cian Healthcare's Bank Loans; Outlook Stable MT
Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2022 CI
Cian Healthcare Limited Announces Resignation of Santosh Pimparkar as Wholetime Director CI
Cian Healthcare Gets Board's Approval to Move Shares to BSE's Main Board MT
Cian Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Cian Healthcare Limited Appoints Paresh Arun Shah as Additional Director, Date of Appointment Is 25 August, 2022 CI
Cian Healthcare Limited Announces Resignation of Damodarkumar Sharma as Wholetime Director CI
4,900,000 Equity Shares of Cian Healthcare Limited are subject to a Lock-Up Agreement Ending on 30-MAY-2022. CI
Cian Healthcare Limited Announces Resignation of Mohammad Raees Sheikh as Non-Executive Independent Director CI
Cian Healthcare Limited Announces Resignation of Shikha Rai as Independent Non-Executive Director CI
Cian Healthcare Limited Announce Change in Corporate Office CI
Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2021 CI
Cian Healthcare Widens Consolidated Net Loss in Fiscal H1 MT
Cian Healthcare Limited Announces Board Changes CI
Cian Healthcare Limited announced a financing transaction CI
Cian Healthcare Limited Announces the Resignation of Dhiraj Shantilal Ostwal as Non-Executive Additional Director of the Company CI
Cian Healthcare Limited Reports Standalone Earnings Results for the Year Ended March 31, 2021 CI
Chart Cian Healthcare Limited
More charts
Cian Healthcare Limited is an India-based company, which is engaged in the manufacturing and marketing of pharmaceutical products. The Company is engaged in manufacturing of multiple lines-tablets, capsules, soft gels, liquid orals, ointments/ creams and sachets, cosmetics. The Company operates in five sectors, such as Export, Government Supplies, Merchant Export, Own Brand Franchise Business and Third Party/ Contract manufacturing. Its portfolio comprises gynecology, haematinic, cardio- diabetic, orthopedic, pediatric, derma-cosmetic, and antibiotic, CNS, vitamin and nutrient products. The Company also exports its product to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, Sri Lanka, Myanmar and also enhances its production capacity by installing additional machinery for manufacturing a variety of products. It is also engaged in the business of manufacturing cosmetic products. The Company's subsidiary includes Dr. Smith Biotech Private Limited.
More about the company
  1. Stock Market
  2. Equities
  3. CHCL Stock
  4. News Cian Healthcare Limited
  5. Crisil Lowers Rating on Cian Healthcare's Bank Loans to D; Outlook